These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 34659584)

  • 21. Mindfulness-based relapse prevention for alcohol dependence: Findings from a randomized controlled trial.
    Zgierska AE; Burzinski CA; Mundt MP; McClintock AS; Cox J; Coe CL; Miller MM; Fleming MF
    J Subst Abuse Treat; 2019 May; 100():8-17. PubMed ID: 30898331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Trauma-Integrated Mindfulness-Based Relapse Prevention for Women with Comorbid Post-Traumatic Stress Disorder and Substance Use Disorder: A Cluster Randomized Controlled Feasibility and Acceptability Trial.
    Somohano VC; Bowen S
    J Integr Complement Med; 2022 Sep; 28(9):729-738. PubMed ID: 35648046
    [No Abstract]   [Full Text] [Related]  

  • 23. Approach coping and substance use outcomes following mindfulness-based relapse prevention among individuals with negative affect symptomatology.
    Roos C; Bowen S; Witkiewitz K
    Mindfulness (N Y); 2020 Oct; 11(10):2397-2410. PubMed ID: 33510820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pilot study of mindfulness-based relapse prevention for compulsive sexual behaviour disorder.
    Holas P; Draps M; Kowalewska E; Lewczuk K; Gola M
    J Behav Addict; 2020 Nov; 9(4):1088-1092. PubMed ID: 33216012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retraining the addicted brain: a review of hypothesized neurobiological mechanisms of mindfulness-based relapse prevention.
    Witkiewitz K; Lustyk MKB; Bowen S
    Psychol Addict Behav; 2013 Jun; 27(2):351-365. PubMed ID: 22775773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mindfulness-Based Relapse Prevention for Substance Use Disorders: Effects on Cardiac Vagal Control and Craving Under Stress.
    Carroll H; B Lustyk MK
    Mindfulness (N Y); 2018 Apr; 9(2):488-499. PubMed ID: 34025815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mindfulness-based relapse prevention for substance craving.
    Witkiewitz K; Bowen S; Douglas H; Hsu SH
    Addict Behav; 2013 Feb; 38(2):1563-1571. PubMed ID: 22534451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of Mindfulness-Based Relapse Prevention in Individuals with Substance Use Disorders: A Systematic Review.
    Ramadas E; Lima MP; Caetano T; Lopes J; Dixe MDA
    Behav Sci (Basel); 2021 Sep; 11(10):. PubMed ID: 34677226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mindfulness Based Relapse Prevention for Stimulant Dependent Adults: A Pilot Randomized Clinical Trial.
    Glasner-Edwards S; Mooney LJ; Ang A; Garneau HC; Hartwell E; Brecht ML; Rawson RA
    Mindfulness (N Y); 2017 Feb; 8(1):126-135. PubMed ID: 28191264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mindfulness-Based Relapse Prevention in a Jail Drug Treatment Program.
    Lyons T; Womack VY; Cantrell WD; Kenemore T
    Subst Use Misuse; 2019; 54(1):57-64. PubMed ID: 30409061
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mindfulness-based relapse prevention for substance use disorders: a pilot efficacy trial.
    Bowen S; Chawla N; Collins SE; Witkiewitz K; Hsu S; Grow J; Clifasefi S; Garner M; Douglass A; Larimer ME; Marlatt A
    Subst Abus; 2009; 30(4):295-305. PubMed ID: 19904665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot randomized controlled trial of mindfulness-based relapse prevention vs cognitive behavioral therapy for smoking and alcohol use.
    Vinci C; Sutton SK; Yang MJ; Baban S; Sauls R; Witkiewitz K; Brandon KO; Unrod M; Brandon TH; Wetter DW
    Drug Alcohol Depend; 2023 Mar; 244():109768. PubMed ID: 36645978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Individual gender and group gender composition as predictors of differential benefit from mindfulness-based relapse prevention for substance use disorders.
    Roos C; Stein E; Bowen S; Witkiewitz K
    Mindfulness (N Y); 2019 Aug; 10(8):1560-1567. PubMed ID: 31741686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing the Efficacy of Mindfulness-Based Relapse Prevention Versus Relapse Prevention for Alcohol Use Disorder: A Randomized Control Trial.
    Skrzynski CJ; Karoly H; Ellingson JM; Hagerty SL; Bryan AD; Hutchison KE
    J Stud Alcohol Drugs; 2023 Jul; 84(4):560-569. PubMed ID: 36971735
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreases in the Late Positive Potential to Alcohol Images Among Alcohol Treatment Seekers Following Mindfulness-Based Relapse Prevention.
    Brown DR; Jackson TCJ; Claus ED; Votaw VR; Stein ER; Robinson CSH; Wilson AD; Brandt E; Fratzke V; Clark VP; Witkiewitz K
    Alcohol Alcohol; 2020 Feb; 55(1):78-85. PubMed ID: 31825472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mindfulness-Based Relapse Prevention for Methadone Maintenance: A Feasibility Trial.
    Bowen S; Somohano VC; Rutkie RE; Manuel JA; Rehder KL
    J Altern Complement Med; 2017 Jul; 23(7):541-544. PubMed ID: 28488881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Pretreatment Expectancy on Substance Use Outcomes in Women Mandated to Mindfulness-Based Relapse Prevention.
    Somohano VC; Shank T; Manuel J; Mallik D; Rehder K; Bowen S
    J Altern Complement Med; 2021 Dec; 27(12):1147-1155. PubMed ID: 34516782
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluating substance use treatment efficacy for younger and older adults.
    Dingle T; Bowen S
    Addict Behav; 2021 Jan; 112():106618. PubMed ID: 32889444
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The (Lack of) Replication of Self-Reported Mindfulness as a Mechanism of Change in Mindfulness-Based Relapse Prevention for Substance Use Disorders.
    Hsiao YY; Tofighi D; Kruger ES; Lee Van Horn M; MacKinnon DP; Witkiewitz K
    Mindfulness (N Y); 2019 Apr; 10(4):724-736. PubMed ID: 30931014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mindfulness-based Relapse Prevention for Substance Use Disorders: A Systematic Review and Meta-analysis.
    Grant S; Colaiaco B; Motala A; Shanman R; Booth M; Sorbero M; Hempel S
    J Addict Med; 2017; 11(5):386-396. PubMed ID: 28727663
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.